Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Acquisitions: 2022-2023

Historic Acquisitions for Maravai Lifesciences Holdings (MRVI) over the last 2 years, with Dec 2023 value amounting to $69.6 million.

  • Maravai Lifesciences Holdings' Acquisitions was N/A to $362,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $88.6 million, marking a year-over-year change of. This contributed to the annual value of $69.6 million for FY2023, which is 70.87% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Acquisitions of $69.6 million as of FY2023, which was down 70.87% from $239.0 million recorded in FY2022.
  • Maravai Lifesciences Holdings' Acquisitions' 5-year high stood at $239.0 million during FY2022, with a 5-year trough of $69.6 million in FY2023.
  • For the 2-year period, Maravai Lifesciences Holdings' Acquisitions averaged around $154.3 million, with its median value being $154.3 million (2022).
  • Data for Maravai Lifesciences Holdings' Acquisitions shows a maximum YoY plummeted of 70.87% (in 2023) over the last 5 years.
  • Yearly analysis of 2 years shows Maravai Lifesciences Holdings' Acquisitions stood at $239.0 million in 2022, then crashed by 70.87% to $69.6 million in 2023.